Opinion|Videos|July 10, 2024
Key Financial Factors Associated With Typical PNH Treatment Journey
Dr Haumschild and a panel of medical experts underscore financial considerations in PNH treatment.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Please walk us through the typical patient journey for individuals with PNH, highlighting the key touchpoints, challenges, and unmet needs encountered along the way.
- What challenges, beyond coverage approval, have you faced in ensuring seamless access to PNH medications for patients, and how do financial factors impact your treatment decisions?
Advertisement
Related to this article
Adults with moderately to severely active Crohn disease can now start risankizumab with an on-body injector at home.
For all the advances in breast cancer, there remains unmet need for patients whose cancer progresses after treatment with antibody-drug conjugates (ADCs). In the final week of Breast Cancer Awareness Month, AJMC® looks at an investigational vaccine approach that could come after ADCs, offering patients a low-toxicity regimen.
Hiddo Heerspink, PhD, discusses finerenone data in type 1 diabetes, FSGS and IgA nephropathy, and open questions on sequencing CKD therapies.
Advertisement
Advertisement
Trending on AJMC
1
IDWeek Studies Tie RSV, Flu, and COVID-19 to Harm After Acute Illness
2
Preparing for Hepatitis B Functional Cure: Jordan Feld, MD, MPH
3
Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36
4
Nephrologists Weigh Wins, Losses From 5 Years of Value-Based Kidney Care
5